Last reviewed · How we verify
dexmedetomidine combined with remifentanil
dexmedetomidine combined with remifentanil is a Small molecule drug developed by Nanjing First Hospital, Nanjing Medical University. It is currently in Phase 1 development. Also known as: dexmedetomidine-remifentanil.
At a glance
| Generic name | dexmedetomidine combined with remifentanil |
|---|---|
| Also known as | dexmedetomidine-remifentanil |
| Sponsor | Nanjing First Hospital, Nanjing Medical University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery. (NA)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Tubeless Strategy in Lung Transplantation: A Prospective Single-Arm Study (NA)
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Inhalational Agents Versus Dexmedetomidine for Maintenance of General Anesthesia (NA)
- Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients (PHASE4)
- Night-time Dexmedetomidine-esketamine Infusion and Sleep Quality in ICU Patients (PHASE4)
- Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dexmedetomidine combined with remifentanil CI brief — competitive landscape report
- dexmedetomidine combined with remifentanil updates RSS · CI watch RSS
- Nanjing First Hospital, Nanjing Medical University portfolio CI
Frequently asked questions about dexmedetomidine combined with remifentanil
What is dexmedetomidine combined with remifentanil?
dexmedetomidine combined with remifentanil is a Small molecule drug developed by Nanjing First Hospital, Nanjing Medical University.
Who makes dexmedetomidine combined with remifentanil?
dexmedetomidine combined with remifentanil is developed by Nanjing First Hospital, Nanjing Medical University (see full Nanjing First Hospital, Nanjing Medical University pipeline at /company/nanjing-first-hospital-nanjing-medical-university).
Is dexmedetomidine combined with remifentanil also known as anything else?
dexmedetomidine combined with remifentanil is also known as dexmedetomidine-remifentanil.
What development phase is dexmedetomidine combined with remifentanil in?
dexmedetomidine combined with remifentanil is in Phase 1.
Related
- Manufacturer: Nanjing First Hospital, Nanjing Medical University — full pipeline
- Also known as: dexmedetomidine-remifentanil
- Compare: dexmedetomidine combined with remifentanil vs similar drugs
- Pricing: dexmedetomidine combined with remifentanil cost, discount & access